Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development...

Coda Octopus Group Announces Significantly Advanced Development of Next-GEN 2.0 Diver Augmented Vision Display (DAVD), Team Accelerated Progress during Pandemic Shutdown CODA is under contract for the onward development of the GEN 2.0 DAVD systemCODA and NAVSEA 00C3 currently trialling GEN 2.0 features to Navy Dive Teams during GEN 1.0 roll-out program to the U.S....